Search research articles
Contact Us
Filters
Showing results (1-10 of 86) with videos related to
Page
of 9
Sort By:
Journal of Gynecologic Oncology
|
July 9, 2010
In reply: Tumor-associated lymphocytes expanded ex vivo from malignant ascites
Shin Wha Lee, Yong-Man Kim
Journal of Gynecologic Oncology
|
December 29, 2016
An open-label, multicenter, phase I trial of a cremophor-free, polymeric micelle formulation of paclitaxel combined with carboplatin as a first-line treatment for advanced ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG-3016)
Shin Wha Lee, Yong Man Kim, Young Tae Kim, et al.
Cancer Research and Treatment
|
May 16, 2023
Safety and Tolerability of Weekly Genexol-PM, a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel, with Carboplatin in Gynecologic Cancer: A Phase I Study
So Hyun Nam, Shin-Wha Lee, Young-Jae Lee, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
February 23, 2013
Simultaneous suppression of Src and signal transducer and activator of transcription 3 inhibits the growth of epithelial ovarian cancer cells
Shin-Wha Lee, Jin Yoo, Soo-Hyoung Lee, et al.
Obstetrics & Gynecology Science
|
May 30, 2015
Long (27-nucleotides) small inhibitory RNAs targeting E6 protein eradicate effectively the cervical cancer cells harboring human papilloma virus
Jun Sik Cho, Shin-Wha Lee, Yong-Man Kim, et al.
Journal of Chemotherapy (Florence, Italy)
|
June 23, 2010
The efficacy and toxicity of belotecan (CKD-602), a camptothericin analogue topoisomerase I inhibitor, in patients with recurrent or refractory epithelial ovarian cancer
Yong-Man Kim, Shin Wha Lee, Dae-Yeon Kim, et al.
Journal of Gynecologic Oncology
|
March 20, 2019
Prospective study of the efficacy and utility of TP53 mutations in circulating tumor DNA as a non-invasive biomarker of treatment response monitoring in patients with high-grade serous ovarian carcinoma
Yong Man Kim, Shin Wha Lee, Young Jae Lee, et al.
International Journal of Molecular Sciences
|
October 9, 2019
An Improved Prediction Model for Ovarian Cancer Using Urinary Biomarkers and a Novel Validation Strategy
Shin-Wha Lee, Ha-Young Lee, Hyo Joo Bang, et al.
Journal of Gynecologic Oncology
|
September 28, 2016
Pathologic findings at risk-reducing salpingo-oophorectomy (RRSO) in germline BRCA mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in germline BRCA mutation carriers
Young Jae Lee, Shin Wha Lee, Kyu Rae Kim, et al.
Scientific Reports
|
May 24, 2024
Transcriptome profiling and characterization of peritoneal metastasis ovarian cancer xenografts in humanized mice
Sung Wan Kang, Ji-Young Lee, Ok-Ju Kang, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 86) with videos related to
Sort By:
Page
of 9
Journal of Gynecologic Oncology
|
July 9, 2010
In reply: Tumor-associated lymphocytes expanded ex vivo from malignant ascites
Shin Wha Lee, Yong-Man Kim
Journal of Gynecologic Oncology
|
December 29, 2016
An open-label, multicenter, phase I trial of a cremophor-free, polymeric micelle formulation of paclitaxel combined with carboplatin as a first-line treatment for advanced ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG-3016)
Shin Wha Lee, Yong Man Kim, Young Tae Kim, et al.
Cancer Research and Treatment
|
May 16, 2023
Safety and Tolerability of Weekly Genexol-PM, a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel, with Carboplatin in Gynecologic Cancer: A Phase I Study
So Hyun Nam, Shin-Wha Lee, Young-Jae Lee, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
February 23, 2013
Simultaneous suppression of Src and signal transducer and activator of transcription 3 inhibits the growth of epithelial ovarian cancer cells
Shin-Wha Lee, Jin Yoo, Soo-Hyoung Lee, et al.
Obstetrics & Gynecology Science
|
May 30, 2015
Long (27-nucleotides) small inhibitory RNAs targeting E6 protein eradicate effectively the cervical cancer cells harboring human papilloma virus
Jun Sik Cho, Shin-Wha Lee, Yong-Man Kim, et al.
Journal of Chemotherapy (Florence, Italy)
|
June 23, 2010
The efficacy and toxicity of belotecan (CKD-602), a camptothericin analogue topoisomerase I inhibitor, in patients with recurrent or refractory epithelial ovarian cancer
Yong-Man Kim, Shin Wha Lee, Dae-Yeon Kim, et al.
Journal of Gynecologic Oncology
|
March 20, 2019
Prospective study of the efficacy and utility of TP53 mutations in circulating tumor DNA as a non-invasive biomarker of treatment response monitoring in patients with high-grade serous ovarian carcinoma
Yong Man Kim, Shin Wha Lee, Young Jae Lee, et al.
International Journal of Molecular Sciences
|
October 9, 2019
An Improved Prediction Model for Ovarian Cancer Using Urinary Biomarkers and a Novel Validation Strategy
Shin-Wha Lee, Ha-Young Lee, Hyo Joo Bang, et al.
Journal of Gynecologic Oncology
|
September 28, 2016
Pathologic findings at risk-reducing salpingo-oophorectomy (RRSO) in germline BRCA mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in germline BRCA mutation carriers
Young Jae Lee, Shin Wha Lee, Kyu Rae Kim, et al.
Scientific Reports
|
May 24, 2024
Transcriptome profiling and characterization of peritoneal metastasis ovarian cancer xenografts in humanized mice
Sung Wan Kang, Ji-Young Lee, Ok-Ju Kang, et al.
Page
of 9